FDA Inspection 1295866 — Bruce Tapiero, MD
The FDA completed an inspection of Bruce Tapiero, MD on December 11, 2025 in Montreal. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 11, 2025
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Montreal (Canada)
Additional Details
Clinical Investigator (CI)